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abstract
 
Peptide toxins are invaluable tools for studying the structure and physiology of ion channels.
Pseudechetoxin (PsTx) is the ﬁrst known peptide toxin that targets cyclic nucleotide–gated (CNG) ion channels,
which play a critical role in sensory transduction in the visual and olfactory systems. PsTx inhibited channel cur-
rents at low nM concentrations when applied to the extracellular face of membrane patches expressing olfactory
CNGA2 subunits. Surprisingly, 500 nM PsTx did not inhibit currents through channels formed by the CNGA3 sub-
unit from cone photoreceptors. We have exploited this difference to identify the PsTx-binding site on the extracel-
lular face of CNG channels. Studies using chimeric channels revealed that transplantation of the pore domain
from CNGA2 was sufﬁcient to confer high afﬁnity PsTx binding upon a CNGA3 background. To further deﬁne the
binding site, reciprocal mutations were made at 10 nonidentical amino acid residues in this region. We found that
two residues in CNGA2, D316 and Y321, were essential for high-afﬁnity inhibition by PsTx. Furthermore, replace-
ment of both residues was required to confer high-afﬁnity PsTx inhibition upon CNGA3. Several other residues, in-
cluding E325, also form favorable interactions with PsTx. In the CNGA2-E325K mutant, PsTx afﬁnity was reduced
 
by 
 
 
 
5-fold to 120 nM. An electrostatic interaction with D316 does not appear to be the primary determinant of
PsTx afﬁnity, as modiﬁcation of the D316C mutant with a negatively charged methanethiosulfonate reagent did
not restore high afﬁnity inhibition. The residues involved in PsTx binding are found within the pore turret and he-
lix, in similar positions to residues that form the receptor for pore-blocking toxins in voltage-gated potassium chan-
nels. Furthermore, biophysical properties of PsTx block, including an unfavorable interaction with permeant ions,
also suggest that it acts as a pore blocker. In summary, PsTx seems to occlude the entrance to the pore by forming
high-afﬁnity contacts with the pore turret, which may be larger than that found in the KcsA structure.
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INTRODUCTION
 
Peptide toxins that target ion channels have been ob-
tained from the venoms of many poisonous creatures,
including scorpions, snakes, spiders, and cone shells (Ol-
ivera et al., 1991, 1995; Garcia et al., 2001; Harvey, 2001;
Rash and Hodgson, 2002). Over the past several de-
cades, these peptide toxins have played a crucial role in
the study of ion channel structure, function, and physiol-
ogy. Originally, these toxins were used as speciﬁc high-
afﬁnity ligands that facilitated the identiﬁcation and pu-
riﬁcation of several ion channels. Fluorescent versions of
bungarotoxin, charybdotoxin, and apamin have been
widely used as tools to study the subcellular distribution
and cell biology of nicotinic acetylcholine receptors and
calcium-activated potassium channels. Finally, these tox-
ins have been used in structure-function studies to iden-
tify structural elements of ion channels and gating mech-
anisms. In fact, studies with charybdotoxin gave us the
ﬁrst glimpse of the structure of an ion channel pore. By
identifying the extracellular residues that comprised
the charybdotoxin-binding site on the 
 
Shaker
 
 potassium
channel, MacKinnon, Miller, and Yellen ﬁrst postulated
the existence of a reentrant pore loop (MacKinnon and
Miller, 1989; Yellen et al., 1991).
Studies of peptide toxins that target voltage-gated ion
channels have resulted in the discovery of toxins with
two distinct modes of action. Some ion channel tox-
ins, such as agitoxin, charybdotoxin, and 
 
 
 
-conotoxin-
GVIA, are known to function as simple pore blockers
that physically occlude the entry of ions into the trans-
membrane pore (MacKinnon et al., 1990; Ellinor et al.,
1994; Garcia et al., 1994; Feng et al., 2001). Other pep-
tide antagonists, such as hanatoxin, grammotoxin, and
 
 
 
-agatoxin-IVA, are known as gating modiﬁers because
they allosterically inhibit structural rearrangements
that are involved in channel activation (Mintz et al.,
1992; Lampe et al., 1993; Swartz and MacKinnon,
1995). The mechanism of action of these two types of
toxins can be largely predicted by the location of their
binding sites. Pore blockers typically bind to the amino
acid residues in the pore turret and nearby residues
that form the extracellular vestibule at the mouth
of the transmembrane pore (MacKinnon and Miller,
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1989; MacKinnon et al., 1990; Gross et al., 1994; Gross
and MacKinnon, 1996). In contrast, gating-modiﬁer
toxins recognize conserved structural features found
on the extracellular face of the voltage sensor. In volt-
age-gated calcium and potassium channels, gating-
modiﬁer toxins typically bind to residues located at the
extracellular end of the third transmembrane helix
(S3) (Swartz and MacKinnon, 1997; Bourinet et al.,
1999; Winterﬁeld and Swartz, 2000). Binding of these
toxins impairs the structural rearrangements necessary
for channel activation, thereby stabilizing the closed or
inactivated states of the channel.
CNG ion channels were ﬁrst discovered in the sensory
epithelium of the visual and olfactory systems (for a re-
view see Kaupp and Seifert, 2002). In both photorecep-
tors and olfactory neurons, CNG channels convert stim-
ulus-induced changes in the intracellular concentration
of cyclic nucleotides into changes in membrane poten-
tial. In this manner, they control the release of neu-
rotransmitter at the synapse. Currently, six CNG chan-
nel subunits are known (Kaupp et al., 1989; Dhallan et
al., 1990; Chen et al., 1993; Biel et al., 1994; Bradley et
al., 1994; Liman and Buck, 1994; Weyand et al., 1994;
Korschen et al., 1995; Gerstner et al., 2000; Bradley et
al., 2001). Although they are not activated by changes
in membrane voltage, CNG channels are members of
the voltage-gated ion channel superfamily on the basis
of their subunit structure. Each subunit contains a
transmembrane domain with six transmembrane heli-
ces (S1–6) and a reentrant pore loop between S5 and
S6 (Heginbotham et al., 1992). When expressed indi-
vidually in oocytes or HEK-293 cells, the CNGA1, 2, and
3 subunits form functional CNG channels. In contrast,
CNGA4 and the 
 
 
 
-subunits, CNGB1 and CNGB3, do
not form functional channels, although they possess a
similar structure. However, the 
 
 
 
-subunits coassemble
with CNGA1–3 to form native channels, and confer dis-
tinct properties in terms of ligand afﬁnity, regulation,
and ion permeation. The native rod photoreceptor
CNG channel has a stoichiometry of 3 A1:1 B1 subunits
(Weitz et al., 2002; Zheng et al., 2002; Zhong et al.,
2002). The native olfactory CNG channel is composed
of three distinct subunit types, including CNGA2,
CNGA4, and a splice variant of CNGB1 (Sautter et al.,
1998; Bonigk et al., 1999), while cone photoreceptor
channels contain CNGA3 and CNGB3 (Gerstner et al.,
2000). In the past decade, CNG channels have been dis-
covered in nonsensory tissues through out the body, in-
cluding the brain, heart, liver, kidneys, and skeletal
muscle (Finn et al., 1996). However, the function of
CNG channels in these tissues remains obscure, largely
due to the lack of speciﬁc CNG channel antagonists.
Recently, we puriﬁed and cloned pseudechetoxin
from the venom of the Australian King Brown snake,
 
Pseudechis australis
 
 (Brown et al., 1999; Yamazaki et al.,
2002). Pseudechetoxin (PsTx) was the ﬁrst peptide
toxin known to target CNG channels and inhibits CNG
channel currents with high afﬁnity when applied to the
extracellular face of membrane patches expressing
CNGA1 or CNGA2. Surprisingly, in subsequent studies
we found that CNG channels formed by the CNGA3
subunit from cone photoreceptors were immune to
block by PsTx. In the current study, we have exploited
this selectivity to identify residues on the extracellular
face of CNG channels that are critical for high-afﬁnity
interaction with PsTx. Binding of PsTx is also weak-
ened by an unfavorable interaction with permeant ions,
a phenomenon known as “knock-off” (MacKinnon and
Miller, 1988). The results indicate that PsTx forms sev-
eral contacts with the pore turret region of CNG chan-
nels and inhibits channel activity by occluding extracel-
lular access to the transmembrane pore.
 
MATERIALS AND METHODS
 
Pseudechis australis
 
 venom was purchased from Venom Supplies Pty.
Ltd. PsTx was puriﬁed as described previously (Brown et al., 1999).
The plasmid encoding bovine CNGA1 was the gift of Dr. W.N. Za-
gotta (University of Washington, Seattle, WA). CNGA2 was a gift of
Dr. R. Reed (Johns Hopkins University), and CNGB1 was the gift
of Dr. Robert Molday (University of British Columbia). Plasmids
encoding CNGA3, CNGB1.3, and CNGA4 were the gifts of Drs.
M. Biel and A. Gerstner (Ludwig Maximilians University, Mu-
nich, Germany). Cyclic nucleotides, including 
 
p
 
-chlorophenylthio-
cGMP (CPT-cG), were from Sigma-Aldrich. Methanethiosulfonate
(MTS) reagents were purchased from Toronto Research Chemi-
cals. All other chemicals were of analytical grade or better.
 
Construction of Chimeric CNG Channels and Mutants
 
For the construction of chimeric CNG channels, unique restric-
tion sites were created between each of the extracellular loops us-
ing silent mutations. A KpnI site was inserted between transmem-
brane helices S2 and S3 in both CNGA2 and CNGA3, a Kpn2I
site was inserted between S4 and S5, and a BstBI site was inserted
after S6 in CNGA3. These two sites were already present in
CNGA2. An additional BstBI site was removed from the S3 re-
gion of CNGA3. These mutations allowed the creation of several
chimeric CNG channels. Splice sites were after S229, I277, and
R401 in CNGA2 and after V276, I322, and R446 in CNGA3. Chi-
meras are named by indicating the source of each of the four
channel segments. For instance, the chimera 2-2-3-2 would con-
tain the NH
 
2
 
 terminus and S1–4 of CNGA2, the S5-P-S6 region
from CNGA3, and the COOH terminus from CNGA2.
Point mutations were created using the Quick Change kit
(Stratagene). After sequence conﬁrmation, the relevant restric-
tion fragment containing the S5-P-S6 region was subcloned into
the appropriate CNG channel sequence to prevent second site
mutations. Point mutations are named by the number of the par-
ent subunit, followed by the wild-type amino acid, its position,
and its replacement. Therefore, the mutant 2-D316N is a point
mutation in CNGA2, in which the wild-type D316 is replaced with
N, from the corresponding position in CNGA3.
 
Expression of CNG Channels in Xenopus Oocytes
 
The coding sequences for CNGA1, A2, and A3 were inserted into
the pGEMHE vector, which promotes high expression levels by in-
corporating ﬂanking sequences from the 
 
Xenopus
 
 
 
 
 
-globin geneT
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(Liman et al., 1992). For in vitro transcription, the plasmids were
linearized with PstI (CNGA1) or NheI (CNGA2 and CNGA3).
Complementary RNA was transcribed from the T7 promoter and
capped using the mMessage mMachine kit (Ambion). 
 
Xenopus
 
 oo-
cytes were prepared and injected with cRNA (10–20 ng) by stan-
dard methods. After injection, oocytes were maintained at 18
 
 
 
C for
3–7 d in ND 96 media containing 50 
 
 
 
g/ml gentamycin.
 
Electrophysiology on Oocytes
 
Recording electrodes were pulled from borosilicate glass (World
Precision Instruments) on a P97 Brown-Flaming puller (Sutter)
and polished on a microforge (Life Science Resources) to a resis-
tance of 1–2 M
 
 
 
. Recordings were made in symmetrical solutions
containing 130 mM NaCl, 3 mM HEPES (pH 7.2), and 0.2 mM
EDTA. The electrode solution contained 1 mM cyclic GMP to ac-
tivate CNG channels. Currents were recorded from patches in
the outside-out conﬁguration using an Axopatch 200A ampliﬁer
(Axon Instruments, Inc.) driven by pClamp 8.0 software via a
Digidata 1200 interface (Axon Instruments, Inc.). Typically, 250-
ms voltage pulses, ranging from 
 
 
 
100 to 
 
 
 
 100 mV, were given
from a holding potential of 0 mV. Records were typically sampled
at 10 kHz and ﬁltered at 2 kHz. Solutions were applied to the ex-
tracellular face of the patch via the “sewer pipe” method using an
RSC-100 rapid perfusion system (Biologic; Molecular Kinetics).
The seal resistance and “leak” currents were estimated after ap-
plication of a solution containing 10 mM MgCl
 
2
 
, which blocks
 
 
 
98% of the current at –60 mV in all CNG channels studied. So-
lutions containing toxin were supplemented with 50 
 
 
 
g/ml bo-
vine serum albumin to prevent nonspeciﬁc surface adsorption.
PsTx concentration was estimated based on the calculated molar
extinction coefﬁcient of 21.6 cm
 
 
 
1
 
 for a 10 mg/ml solution
(Yamazaki et al., 2002). MTS reagents were tested to ensure their
viability based on their ability to shift the cyclic nucleotide sensi-
tivity of CNGA1 by modiﬁcation of C481 (Brown et al., 1998).
 
Growth and Transfection of HEK-293 cells
 
Human embryonic kidney cells (HEK-293) were maintained in
DMEM culture medium (Sigma-Aldrich) supplemented with
10% fetal bovine serum and a penicillin/streptomycin mixture at
37
 
 
 
C in 5% CO
 
2
 
. Cells were split 1 d before transfection and
grown to 50–70% conﬂuence in a T-25 culture ﬂask. Cells were
transfected with plasmids encoding CNG channel subunits by
treatment with Effectene (QIAGEN) following manufacturer’s
instructions. Brieﬂy, the culture media was aspirated and re-
placed with 1 ml DMEM containing a total of 2 
 
 
 
g of plasmid
DNA, 50 
 
 
 
l effectene, and 16 
 
 
 
l effectene enhancer. All transfec-
tions contained 0.5 
 
 
 
g of a plasmid encoding EGFP (CLON-
TECH Laboratories, Inc.), and 1.5 g of plasmid DNA encoding
CNG channel subunits. For cotransfection of multiple subunit
types, the ratio of DNA encoding the primary subunits (CNGA1,
A2, or A3) to CNGA4 and/or B1 was 1:1. After 6 h, the transfec-
tion mix was removed by aspiration. The cells were lifted with
trypsin/EDTA, and replated at a low density on glass coverslips.
To prevent further growth and maintain isolated cells, the media
was supplemented with the mitotic blocker FUDR (200 
 
 
 
g/ml 5
 
 
 
ﬂuoro-2-deoxyuridine and 500 
 
 
 
g/ml uridine). For whole-cell
experiments, recording was performed 18–36 h after transfec-
tion. Excised patch experiments were performed 24–72 h after
transfection to allow expression of larger currents and better ad-
herence to the coverslip substrate.
 
Electrophysiology on HEK-293 Cells
 
Coverslips containing transfected cells were rinsed in serum-free
media and placed in a recording chamber (Warner Instruments)
on the stage of a Nikon inverted microscope. Electrodes had re-
sistances between 2.0–3.5 M
 
 
 
 when ﬁlled with an internal solu-
tion containing 145 mM KCl, 5 mM NaCl, 0.5 mM MgCl
 
2
 
 (to
maintain seal integrity), and 5 mM HEPES, pH 7.4. In some ex-
periments, the internal solution also contained 1 mM cGMP
(Na
 
 
 
 salt; Sigma-Aldrich). Transfected cells were identiﬁed un-
der epiﬂuorescent illumination (EGFP ﬁlter cube; Chroma Tech-
nology Corp.) by green ﬂuorescence due to GFP expression. The
initial G
 
 
 
 seals were obtained in an external solution containing
145 mM NaCl, 5 mM KCl, 5 mM MgCl
 
2
 
, 2 mM CaCl
 
2
 
, and 5 mM
Hepes, pH 7.4. For whole-cell recording, the patch was ruptured
with a 2-ms pulse of 1.3 V using the Zap feature of the patch-
clamp ampliﬁer. After obtaining a whole-cell conﬁguration, the
cells were gently lifted from the coverslip and placed in front of a
quartz micromanifold (ALA Scientiﬁc). The cell capacitance
(10–20 pF) and series resistance (5–15 M
 
 
 
) were electronically
compensated by 60–70%. Cells were perfused using a computer
controlled DAD-12 system (ALA Scientiﬁc). For the measure-
ment of current through CNG channels, divalent cations were
omitted from the external solution described above. CNG chan-
nel currents were evoked by perfusion with external solution
containing 1 mM CPT-cG, and leak currents were estimated be-
fore channel activation. An Axopatch 200A ampliﬁer (Axon In-
struments, Inc.) controlled by PClamp 8 software was used to
control voltage pulses and acquire current records. Cells were
held at 0 mV and given 50–250-ms voltage pulses to potentials
ranging from 
 
 
 
100 to 
 
 
 
100 mV. Records were typically sampled
at 10 kHz and ﬁltered at 2 kHz. Similar conditions were used for
excised inside-out patch recording except that the compositions
of pipet and bath solutions were reversed. The formation of het-
eromeric channels was conﬁrmed by sensitivity to of l-cis-dil-
tiazem, a hallmark of CNG channels containing CNGB1, and
shifts in the dose–response relations for cGMP and cAMP.
 
Data Analysis
 
Data were analyzed using the Clampﬁt program in the pClamp
8.0 suite. Plots were generated using Sigma Plot 2000 (SPSS
Science), and ﬁgures were composed using Adobe Illustrator
(Adobe). Data are reported as mean 
 
 
 
 SD. Statistical signiﬁ-
cance was assessed by the Student’s 
 
t
 
 test. Dose response relations
for cyclic nucleotides were ﬁt by the Hill equation. In Fig. 5, PsTx
afﬁnity was estimated using a modiﬁed form of the Hill equation:
 
RESULTS
 
In previous studies, we identiﬁed PsTx as a high-afﬁnity
blocker of homomeric CNG channels composed of ei-
ther CNGA1 or CNGA2. At the outset of this study, we
were surprised to discover that PsTx was ineffective at
blocking currents through CNG channels composed of
CNGA3, the primary subunit of the CNG channel in
cone photoreceptors. As shown in Fig. 1, when 500 nM
PsTx was applied to outside-out patches excised from
oocytes expressing CNGA1 and CNGA2, it blocked
89% and 98% of the current, respectively, at a test po-
tential of 
 
 
 
60 mV. However, when the same concentra-
tion of PsTx was applied to patches expressing the
CNGA3 subunit, it was almost totally ineffective at
blocking the current. In subsequent experiments, we
exploited this surprising difference to identify residues
II max ⁄ 1 PsTx []
n PsTx []
n KD
n + () ⁄ {} . – =T
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that are critical for high-afﬁnity binding of PsTx to the
extracellular face of CNG channels.
In the ﬁrst set of experiments, we used chimeric
CNG channel constructs to determine if PsTx inhib-
ited channel function by binding to the external
vestibule of the channel pore, like a pore-blocking
toxin, or if it bound to the periphery of the channel
like a gating-modiﬁer toxin. As shown in Fig. 2, trans-
plantation of the S5-P-S6 region from CNGA2 into a
CNGA3 background (chimera 3-3-2-3) was sufﬁcient
to restore high-afﬁnity block by PsTx. Conversely,
PsTx had little effect on the reciprocal chimera 2-2-3-2.
We also tested chimeras in which the NH
 
2
 
-terminal
and S1–S4 regions were swapped between CNGA2
and A3 (unpublished data). All of the chimeric chan-
nels tested retained the approximate afﬁnity of the
channel isoform from which the pore region was de-
rived.
The differences in PsTx afﬁnity are not likely to be
caused by the gross alteration of channel gating prop-
erties. The apparent cGMP afﬁnity and cAMP efﬁcacy
of both 3-3-2-3 and 2-2-3-2 chimeric channels were simi-
lar those of the parent channels, when tested using in-
side-out patches. For the 2232 chimera (N 
 
 
 
 3), the
Figure 1. Differential inhibition of CNG chan-
nels by PsTx. Outside-out patches were excised
from  Xenopus oocytes expressing homomeric
CNG channels composed of CNGA1, 2, or 3 sub-
units. The intracellular solution contained 1 mM
cyclic GMP to activate the channels. Voltage
pulses (250 ms) were applied from a holding po-
tential of 0 mV to potentials ranging from  100
to  100 mV in 20-mV increments. Leak currents
were estimated by application of 10 mM external
MgCl2. Application of 500 nM PsTx blocked 80  
6% (n   5) of current through CNGA1 channels
at   60 mV and 94   3% (n    8) of current
through CNGA2 channels. However, currents
through CNGA3 channels were virtually unaf-
fected by 500 nM PsTx (2   1% block at  60 mV;
n   3). Bars: 1 nA and 50 ms.
Figure 2. The pore region
of CNG channels is the pri-
mary determinant of PsTx af-
ﬁnity. Complementary DNA
encoding chimeric CNG
channels were created by ex-
changing a Kpn2I-BstBI re-
striction fragment between
CNGA2 and CNGA3. This
fragment encompassed the
S5-P-S6 region of the chan-
nels as shown (red indicates
channel sequences derived
from CNGA2, and blue indi-
cates sequences derived from
CNGA3). Currents were re-
corded at  60 mV in the out-
side-out patch conﬁguration.
Trace 1 was recorded in 10
mM MgCl2, trace 2 in control,
and trace 3 in 500 nM PsTx.
Transplantion of the pore re-
gion from CNGA2 into a
CNGA3 background caused inhibition by 500 nM PsTx to increase from 2% in wild-type CNGA3 to 90% in the 3-3-2-3 chimera. Conversely,
inhibition by 500 nM PsTx decreased from 98% in wild-type CNGA2 to 3% in the 2-2-3-2 chimera.T
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cGMP K
 
1/2
 
 was 10.3 
 
 
 
 3 
 
 
 
M and 
 
n
 
 
 
 
 
 2.1 
 
 
 
 0.3, com-
pared with 3.0 
 
 
 
 2 
 
 
 
M and 3.2 
 
 
 
 0.4 for CNGA2. Both
2232 and CNGA2 were activated to a similar extent
(0.92 of the maximum current in saturating cGMP) by
10 mM cAMP. A comparison between 3323 and CNGA3
produced similar ﬁndings. The 3323 chimera was acti-
vated by cGMP with a K
 
1/2
 
 
 
 
 
 20 
 
 
 
 5 
 
 
 
M and 
 
n
 
 
 
 
 
 1.8 
 
 
 
0.3, similar to the values of K
 
1/2
 
 
 
 
 
 18 
 
 
 
 4 
 
 
 
M and 
 
n
 
 
 
 
 
1.7 for CNGA3 (N 
 
 
 
 3). The extent of activation by 10
mM cAMP was similar as well, 0.27 for 3323 versus 0.23
for CNGA3.
Upon examination of the S5-P-S6 region, we noticed
10 positions in the extracellular loop that differed be-
tween CNGA2 and CNGA3 (see Fig. 3). We hypothe-
sized that one or more of these amino acid changes
were responsible for the dramatic reduction in PsTx af-
ﬁnity between CNGA2 and CNGA3. To determine
which positions were critical for high-afﬁnity PsTx inhi-
Figure 3. Sequence comparison of the pore region among CNG channel subunits. Residues that are identical to that found in CNGA2
are shaded. The 10 residues different between CNGA2 and A3 that were mutated in this study are boxed. The black circle represents the
site of glycosylation in CNGA1. Structural features (e.g., pore turret and helix, and the selectivity ﬁlter [SF]) are predicted based on the
structure of the KcsA channel.
Figure 4. Identiﬁcation of amino acid residues involved in PsTx binding. Point mutations were made to exchange amino acids differ-
ences between CNGA2 and CNGA3. All current was normalized to facilitate comparison. (A) Currents were measured at  60 mV in con-
trol (bottom trace), 10 mM MgCl2 (top trace), and 500 nM PsTx (middle trace) for each mutant channel. PsTx blocked all CNGA2 mu-
tants, except 2-D316N and 2-Y321R, with high afﬁnity. Inhibition of 2-D316N and 2-Y321R by 500 nM PsTx was reduced to  5%. No single
point mutation was sufﬁcient to confer high afﬁnity PsTx block upon CNGA3. A signiﬁcant improvement in the block was only observed in
the 3-N366Y channel (15   3%). (B) Histogram comparing block of all mutant channels by 500 nM PsTx. Maximum patch currents were
 1 nA for all mutant channels, except for 2-D316N and 2-Y321R, which were between 0.5 and 0.8 nA, and 3-R366Y and 3-S374C, which
were between 0.1 and 0.3 nA. Error bars indicate standard deviation, and n values are shown.T
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bition, amino acids at each of the 10 positions were
swapped between the two channel isoforms. As shown
in Fig. 4, substitution at 2 of the 10 positions in CNGA2
caused a dramatic reduction in block by 500 nM PsTx.
When D316 or Y321 of CNGA2 was replaced with the
corresponding residue in CNGA3 to form the mutants
2-D316N or 2-Y321R, PsTx block was virtually elimi-
nated. Once again, the dramatic decrease in chan-
nel block by PsTx cannot be explained by dramatic
changes in channel gating. The K1/2 of the 2-D316N
channel for cGMP was 3.50   0.3  M with n   2.60  
0.05 (N   3); for 2-Y321R, the K1/2 for cGMP was 2.75
 M with n   2.66 (N   1). Other mutations in CNGA2
caused little or no change in block by 500 nM PsTx.
However, these experiments were not sensitive to small
changes in PsTx afﬁnity because this concentration of
PsTx is almost 100-fold greater than its Ki for CNGA2.
When we measured PsTx dose–response relations for
several CNGA2 mutants, we found that other residues
in the pore turret made modest contributions to the
PsTx-binding site (Fig. 5). For instance, PsTx afﬁnity
was reduced by fourfold in the 2-E325K mutant chan-
nel (from 32 to 123 nM using this batch of PsTx). Mu-
tations at other residues, including V306, T308, and
T315, had little, if any, effect on PsTx binding. Surpris-
ingly, the mutant channels 2-S301F and 2-T308S dis-
played a modest increase in PsTx afﬁnity, reducing the
Ki for PsTx inhibition to  16 nM, compared with 32
nM for wild-type CNGA2 (Fig. 5).
We then set out to determine the minimum number
of mutations required to confer high-afﬁnity block by
PsTx upon CNGA3. We found that no single mutation
was sufﬁcient to signiﬁcantly increase block by 500 nM
PsTx, although the 3-N361D channel was blocked to a
small degree in some patches (Fig. 6). However, when
this mutation was combined with the 3-R366Y mutation
to form the double mutant, 3-N361D/R366Y, there was
a dramatic increase in PsTx afﬁnity (Fig. 6). The frac-
tional block of 3-R366Y remained almost undetectable
at  2%, and block of 3-N361D improved only margin-
ally to  15%. However, 500 nM PsTx blocked 84% of
the current in the double mutant, approaching that
seen in the 3-3-2-3 chimera and the wild-type CNGA2
channel. Therefore, it appears that these two residues
are both critical for high-afﬁnity inhibition by PsTx. In-
clusion of the 3-K370E mutation as well would be pre-
Figure 5. Mutation of several residues in the pore turret of
CNGA2 cause modest changes in PsTx afﬁnity. (Top) Current
traces obtained at  60 mV are shown for 2-E325K, CNGA2, and
2-S301F. Traces, in order of decreasing magnitude, represent cur-
rents measured in control solution, 25 nM Pstx, 50 nM PsTx, 100
nM PsTx, 500 nM PsTx, and 10 mM MgCl2. (Bottom) Dose res-
pose relations for PsTx inhibition of 2-E325K (123  M), CNGA2
(32  M), and 2-S301F (16  M). Dose–response relations were ﬁt
by a modiﬁed form of the Hill equation with an n value of 1.0.
Figure 6. Mutations at both
N366 and R371 are required
to confer high afﬁnity PsTx
inhibition upon CNGA3.
PsTx inhibition improved
slightly in 3-N366D mutant
channels (15   3%; n   9),
but remained almost unde-
tectable in 3-R371Y (2   1%),
similar to the 2% inhibition
of wild-type CNGA3. How-
ever, high-afﬁnity inhibition
(84    3%; n    4) was re-
stored in the double mutant,
3-N366D/R371Y, beginning
to approach the 94% inhibi-
tion seen in CNGA2.T
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dicted to further increase the PsTx afﬁnity, producing
a channel with afﬁnity similar to that of wild-type
CNGA2.
Because PsTx is a highly basic protein (pI   10.0;
Yamazaki et al., 2002) and the 2-D316N channel muta-
tion caused the loss of a negative charge, we set out to
determine if this mutation eliminated an important
electrostatic interaction. To test this hypothesis, we cre-
ated a CNGA2 channel with a D316C mutation. PsTx
was then applied to the channel after modiﬁcation of
the 2-D316C channel with charged MTS reagents (Fig.
7). As expected, the D316C mutation signiﬁcantly re-
duced the channel’s afﬁnity for PsTx; block by 500 nM
PsTx was reduced from 98% (on wild-type CNGA2) to
 33% for the D316C mutant. If electrostatic interac-
tions play a key role in the interaction at D316, we
would predict that modiﬁcation with MTS-ethylsulfonic
acid (ES), which donates a negative charge, would re-
store high afﬁnity binding, whereas modiﬁcation with
MTS-ethyltrimethylamine (ET), which donates a posi-
tive charge, would further impair PsTx binding. In-
stead, we found that modiﬁcation with either reagent
caused a further decrease in PsTx afﬁnity, resulting in
block of only 17% and 5%, respectively. This result sug-
gests that the interaction surface between PsTx and the
CNGA2 turret is quite tight. Although modiﬁcation of
D316C restores the original negative charge, the extra
bulk of the cysteine adduct is poorly tolerated. A simi-
lar experimental strategy was used to test the contribu-
tion of potential electrostatic interactions at Y321 as
well. The PsTx afﬁnity was also reduced in the 2-Y321C
channel, such that 500 nM PsTx only blocked 77% of
the current. Modiﬁcation with MTSET had little effect
(81% block), but modiﬁcation with MTSES partially re-
stored PsTx afﬁnity (93% block).
Next, we determined the efﬁcacy of PsTx on hetero-
meric CNG channels. For these experiments, the chan-
nels were expressed in HEK-293 cells because of the
time-dependent decline in current seen when hetero-
meric channels containing CNGA2 are expressed in Xe-
nopus oocytes (Bradley et al., 1994; Liman and Buck,
1994). Currents were recorded in the whole-cell conﬁgu-
ration at  50 mV, and channels were activated by super-
fusion with 1 mM p-CPT-cGMP, a membrane-permeant
analogue of cGMP. Fig. 8 A shows currents recorded be-
fore (bottom trace) and after (middle trace) application
of 500 nM PsTx. The top trace in every panel shows an
initial leak current recorded before channel activa-
tion. As expected from the oocyte experiments, 500 nM
PsTx effectively blocked currents through homomeric
CNGA1 and A2 channels, whereas homomeric CNGA3
channels were insensitive to this concentration of PsTx.
This concentration of PsTx also effectively blocked het-
eromeric CNG channels containing CNGA2 A4, but it
was ineffective on channels containing CNGB1, even in
combination with CNGA2 or CNGA2 A4. These results
are representative of measurements on 3–16 cells for
each subunit combination (Fig. 8 B).
Based on the location of the PsTx-binding site, we hy-
pothesized that PsTx functioned as a pore-blocking
toxin, rather than a gating modiﬁer. To further test this
hypothesis, we studied several biophysical properties of
PsTx block, including voltage dependence, state depen-
dence, and interaction with permeant ions. Inhibition
of CNGA2 channels by PsTx was slightly voltage depen-
dent. This voltage dependence of PsTx block was ini-
tially noted as the time-dependent increase of current
during depolarizing voltage pulses to  80 and   100
mV (see Fig. 1), which was interpreted to reﬂect a volt-
age-dependent relief of block. The voltage dependence
was further studied at steady-state by measuring PsTx
dose–response relations at different holding potentials.
In this way, we determined that PsTx inhibited CNGA2
channels with a signiﬁcantly higher afﬁnity at negative
potentials. The Ki at  60 mV was 24   13 nM (n   4)
compared with 180   52 nM (n   3) at  60 mV.
Figure 7. Modiﬁcation of
2-D316C and 2-Y321C with
charged MTS reagents does
not restore high afﬁnity PxTx
inhibition. Inhibition of CNG
channel current was mea-
sured before and after treat-
ment of the patch with the
charged MTS reagents, MT-
SET (positive charge) and
MTSES (negative charge).T
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To further study the voltage dependence of PsTx
block, we measured the kinetics of PsTx wash off at
 60 and   60 mV. In this manner, we determined that
the majority of the PsTx afﬁnity voltage dependence is
due to a ﬁve- to tenfold increase in the off-rate at depo-
larized voltages. Fig. 9 A shows wash-off of PsTx at hold-
ing potentials of  60 and  60 mV. It is apparent that
the off-rate is signiﬁcantly enhanced at  60 mV com-
pared with  60 mV. The traces shown are from consec-
utive PsTx applications on the same patch. The time
course of the PsTx wash-off was ﬁt well by a single-expo-
nential function (gray lines), yielding time constants of
67 s at  60 mV and 7 s at  60 mV. Although there was
substantial variability in the measured off-rates among
patches, there was always a consistent 5–10-fold differ-
ence between the off-rates measured at  60 and  60
mV (n   5) in solutions containing symmetrical 130
mM NaCl. A possible source of the enhanced off rate at
 60 mV is interaction between PsTx and permeant
ions within the channel pore, a phenomenon known as
“knock-off” (MacKinnon and Miller, 1988). As shown in
Fig. 9 B, replacement of 90% of the intracellular Na 
was with the impermeant NMDG  ion decreased the
voltage dependence of the PsTx off-rate. On this patch,
the time constant for wash-off was 20 s at  60 mV and
10 s at  60 mV. Although there was considerable
patch-to-patch variability in the actual rates, the ratio of
the time constants at  60 and  60 mV was always  2.
Therefore, electrostatic “knock-off” by permeant ions
appears to be the primary cause of the voltage depen-
dence of PsTx inhibition of CNG channels.
We also tested the state dependence of CNG channel
block by PsTx using outside-out patches containing ho-
momeric CNGA2 channels. The pipette solution con-
tained either 1 mM cGMP, which fully activated the
channel current, or 2  M cGMP, which activated 10–
20% of the maximal current when applied to excised
inside-out patches. For these experiments, we applied
20 nM PsTx (a concentration near the Ki for PsTx
when the channels are fully activated) for increased
sensitivity to small changes in PsTx afﬁnity. As shown in
Fig. 10, 20 nM PsTx inhibited  50% of the current re-
gardless of the activation state of the CNGA2 channels
(percentage inhibition   48   8% at 1 mM cG (N   3)
and 43   5% at 2  M cG (N   4)). In summary, these
experiments revealed no state dependence in PsTx in-
hibition of currents carried by CNGA2, suggesting little
or no movement in the pore turret during the channel
gating process.
DISCUSSION
PsTx is a member of the cysteine-rich family of secre-
tory proteins (CRISPs), which are characterized by an
Figure 8. PsTx inhibition
of heteromeric CNG chan-
nels. (A) Currents were re-
corded in the whole cell
patch-clamp mode from
HEK-293 cells transfected
with the subunit combina-
tions indicated at the top and
side. Currents were recorded
at a potential of  60 mV, and
the traces indicate the cur-
rents recorded in control
(top), 500 nM PsTx following
channel activation (middle),
and 1 mM CPT-cGMP (bot-
tom). Currents have been
normalized. (B) Histogram
summarizing the effects of
CNG channel subunit compo-
sition on inhibition by 500
nM PsTx. Error bars indicate
standard deviation and N val-
ues are noted.T
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abundance of cysteine residues in the COOH-terminal
one-third of the primary structure (Yamazaki et al.,
2002). Furthermore, PsTx is a highly basic toxin (pI  
10.0) with many of the basic residues clustered near the
NH2 and COOH termini. With a molecular weight ap-
proaching 25 kD, PsTx is almost an order of magnitude
larger than most peptide toxins, such as charybdotoxin
and agitoxin, which are rigid molecules  30 Å across
(Bontems et al., 1991; Krezel et al., 1995). It is difﬁcult
to envision how such a large protein can squeeze into
the narrow conﬁnes of the external vestibule formed by
the four pore turrets; however, PsTx may exhibit a do-
main structure in which a smaller pore-blocking do-
main is fused to a larger domain of unknown function.
At this time little is known about the three-dimensional
structure of PsTx, or which residues are involved in its
interaction with CNGA2. However, some insights can
be gleaned from a comparison with pseudecin, a ho-
mologous toxin puriﬁed from the venom of P. porphyri-
acus (Yamazaki et al., 2002). Although pseudecin exhib-
its 97% identity (203 of 211 residues) with PsTx, its af-
ﬁnity for CNGA2 is reduced by 30-fold, from 15 to 460
nM. The altered residues are clustered in two distinct
regions, suggesting that one of these regions may di-
rectly interact with CNGA2. The ﬁrst three differences
are located between residues 36 and 57, and the sec-
ond, tighter cluster is between 167 and 175 in the pri-
mary structure. Of these six alterations, four would be
expected to result in neutralization of charged residues
in PsTx. In the future, we hope to use PsTx as a molec-
ular caliper for probing the complementary structure
of the CNG channel extracellular vestibule. Of course,
a three-dimensional structure of PsTx, or a homolo-
gous protein, is a prerequisite for these studies.
In the current study, we identiﬁed six residues in the
CNGA2 pore turret region that are involved in PsTx
binding. The location these residues suggests that PsTx
inhibits CNG channel activity simply by blocking the
external entrance to the ion-conducting pore. The lo-
cation of these residues is similar to that of the residues
involved in inhibition of several voltage-dependent po-
tassium channels by agitoxin (Hidalgo and MacKin-
non, 1995; Gross and MacKinnon, 1996; Ranganathan
et al., 1996). However, there may very well be addi-
tional points of contact that were not identiﬁed in this
study because we only studied residues that were not
conserved between CNGA2 and CNGA3. Conserved
residues are also likely to be involved in PsTx binding.
Several residues on the Shaker potassium channel that
lie at the COOH-terminal side of the G-Y-G signature in
Figure 9. Voltage dependence of PsTx dissociation from CNGA2 and interaction with permeant ions. (A) Dissociation of PsTx at hold-
ing potentials of  60 and  60 mV in the presence of symmetrical NaCl. Smooth red lines indicate single exponential ﬁts with time con-
stants of 67 s ( 60 mV) and 7 s ( 60 mV). (B) Dissociation of PsTx at holding potentials of  60 and  60 mV under asymmetrical condi-
tions (13 mM NaCl; 117 NMDG-Cl in the pipette solution). Smooth red lines indicate single exponential ﬁts with time constants of 20 s
( 60 mV) and 10 s ( 60 mV). Solutions changes are indicated by arrows. C, control solution; P, 500 nM PsTx; M, 10 mM MgCl2.T
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the pore loop, just before the S6 helix, have been impli-
cated in the binding the pore-blocker agitoxin. In the
KcsA structure, these residues lie deeper within the
pore and are closer to the ion-conducting pathway. Be-
cause these residues are conserved between CNGA2
and CNGA3, we did not test their interaction with
PsTx. If these residues were involved in PsTx binding, it
would support the idea that a small domain of PsTx
may extend deeply into the external vestibule. Further
experiments, including more extensive scanning mu-
tagenesis, are needed to examine the interaction be-
tween PsTx and CNGA2 in greater detail.
Based on the location of the PsTx-binding site, we
propose that PsTx inhibits the ﬂow of current through
CNG channels by functioning as a high afﬁnity pore
blocker. Subsequent biophysical studies of its mode of
action support this conclusion as well. Block of channel
current is slightly voltage dependent, largely caused by
an unfavorable response to an interaction with per-
meant ions, rather than an extension of PsTx across a
portion of the transmembrane ﬁeld. Occupancy of the
pore by Na  ions seems to accelerate the dissociation of
PsTx at depolarized voltages. When measured in the
presence of symmetrical NaCl solutions, the PsTx off-
rate is enhanced  10-fold by depolarization to  60 mV
compared with  60 mV. In contrast, this voltage de-
pendence is greatly reduced when 90% of the intracel-
lular Na  is replaced with the impermeant NMDG .
This is reminiscent of the “knock-off” phenomenon de-
scribed for the interaction of charybdotoxin with potas-
sium channels (MacKinnon and Miller, 1988).
PsTx inhibition of channels formed by CNGA2 does
not appear to be dependent on the activation state of
the channel. That is, PsTx binds equally well to both
open and closed channels. This suggests that the re-
gions of the pore turret that form the PsTx receptor do
not move signiﬁcantly during the process of channel ac-
tivation. In contrast, Liu and Siegelbaum (2000) have
reported that the pore helix, a region more proximal to
the selectivity ﬁlter, rotates as the channel pore opens.
Mutations in CNGA2 that altered PsTx afﬁnity spanned
a stretch of 25 amino acids, from S301 to E325. In con-
trast, residues in the pore turret of Shaker channels that
are known to affect binding agitoxin extend from
E422 to D431, a span of only 10 residues (Hidalgo and
MacKinnon, 1995; Gross and MacKinnon, 1996; Ranga-
nathan et al., 1996). In agreement with this ﬁnding, the
region forming the pore turret in the KcsA structure is
only 10 amino acids long, stretching from E51 to I60
(Doyle et al., 1998). The ﬁndings of our current study
suggest that the pore turret is more extensive in CNG
channels. This hypothesis is supported by the presence
of a known glycosylation site at N327 in the CNGA1
channel (Rho et al., 2000), which corresponds to V306 in
Figure 10. PsTx inhibition of CNGA2
is not state dependent. Currents were re-
corded from outside-out patches ex-
cised from oocytes expressing CNGA2.
Patch electrodes were ﬁlled with control
solution containing either 1 mM cGMP
or 2  M cGMP as indicated. Traces rep-
resent currents measured in 10 mM
MgCl2 (top), 20 nM PsTx (middle), and
control solution (bottom). In the right-
most panel, the patch current elicited in
2  M cGMP was scaled to that of the 1
mM to facilitate comparison of PsTx
block. Bars: 1 nA and 50 ms.
Figure 11. Contrasting models of the CNG channel pore turret.
The structure of the left-hand subunit is based on the KcsA struc-
ture with a shorter pore turret, and the model that we propose with
a longer pore turret is shown on the left. Amino acid residues that
were mutated in the current study are indicated as balls on the rib-
bon backbone. The strength of interaction is shown by a color
scale, ranging from blue (undetectable) to yellow (weak) to orange
(moderate) to red (strong). The green residue indicates the posi-
tion homologous to that of a known glycosylation site in CNGA1.T
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CNGA2. Therefore, it is highly likely that this residue is
found on the extracellular loop between S5 and the re-
entrant pore loop. If the CNGA1 channel sequence is su-
perimposed directly on the KcsA structure based on an
alignment of the pore sequence, this residue falls in the
transmembrane region of the S5 helix, a position that
would appear untenable for glycosylation. Therefore, we
propose that the pore turret of CNG channels is signiﬁ-
cantly larger than that of KcsA and voltage-gated potas-
sium channels (see Fig. 11). The proposed size of the
CNG channel pore turret is similar to that proposed for
human ether-a-go-go channels based on the binding site of
the novel scorpion toxin, ErgTx (Pardo-Lopez et al.,
2002). The external vestibule of CNG channels may also
have a broader opening, facilitating block by PsTx.
We have reported previously that PsTx is quite ineffec-
tive at blocking heteromeric CNG channels containing
the rod  -subunit, CNGB1 (Brown et al., 1999). As
shown in Fig. 3, the pore turret of CNGB1 has an eight
amino acid deletion compared with the sequence of the
pore turret in the  -subunits. This deletion removes an
extensive portion of the turret that is involved in the in-
teraction with PsTx. The rod channel has recently been
proposed to consist of a stoichiometry of three CNGA1
subunits to one CNGB1 (Weitz et al., 2002; Zheng et al.,
2002; Zhong et al., 2002). In light of this stoichiometry,
we ﬁnd the dramatic loss of PsTx afﬁnity in the hetero-
multimeric channel to be quite surprising. If PsTx
formed strong contacts with all four subunits in the ho-
momultimer, only one of four interactions would be
lost. Likewise, if PsTx interacts strongly with only one of
four subunits, only one of four potential orientations
would be lost. If one-quarter of the binding energy were
lost, the Ki would be predicted to increase from 100 nM
in CNGA1 homomultimers to  5   M in the hetero-
meric channel, whereas the KD of the CNGA1/CNGB1
heteromultimer is  10  M (Brown et al., 1999). These
results suggest that the incorporation of CNGB1 grossly
alters the shape of the external vestibule, or that interac-
tion between PsTx and the CNGB1 is quite deleterious.
The reduced length of the pore turret region in CNGB1
may pinch off the outer vestibule, sterically occluding
the access of PsTx to its primary binding site. In con-
trast, the PsTx afﬁnity is only slightly reduced in hetero-
meric channels formed by CNGA2 and CNGA4, a sub-
unit that has a glutamine in the position homologous to
D316 and an arginine at the position of Y321. In
CNGA2/A4 heteromultimers, block by 500 nM PsTx is
only reduced to 85%, suggesting a KD of  100 nM, com-
pared with 20 nM for the CNGA2 homomultimer. These
results suggest the simple loss of a contact site in
CNGA2/CNGA4 heteromultimers, without a gross dis-
tortion of the external vestibule.
This study constitutes the ﬁrst step toward develop-
ing a model of the extracellular vestibule of CNG chan-
nels. In the short term, our ﬁndings will be useful for
constructing CNG channels with a differential sensitiv-
ity to both cyclic nucleotides and PsTx. These designer
channels will be useful as biosensors for monitoring in-
tracellular levels of cAMP and cGMP near the plasma
membrane (Rich et al., 2001). In the future, informa-
tion about the structure of the extracellular vestibule of
CNG channels may lead to the design of speciﬁc inhibi-
tors of CNG channels, which are sorely needed to fur-
ther our understanding of their physiological roles
throughout the body.
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